Cargando…

Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study

BACKGROUND AND OBJECTIVE: Hypertension can lead to mood disorders that may worsen or ameliorate depending on the type of antihypertensive prescribed. Depression is associated with modifications in basal brain asymmetry particularly that of the frontal cortex, which is involved in blood pressure cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieto, Isabel, Segarra, Ana B., Villarejo, Ana B., de Gasparo, Marc, Martínez-Cañamero, María M., Ramírez-Sánchez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365296/
https://www.ncbi.nlm.nih.gov/pubmed/30044313
http://dx.doi.org/10.1097/HJH.0000000000001884
_version_ 1783393392374317056
author Prieto, Isabel
Segarra, Ana B.
Villarejo, Ana B.
de Gasparo, Marc
Martínez-Cañamero, María M.
Ramírez-Sánchez, Manuel
author_facet Prieto, Isabel
Segarra, Ana B.
Villarejo, Ana B.
de Gasparo, Marc
Martínez-Cañamero, María M.
Ramírez-Sánchez, Manuel
author_sort Prieto, Isabel
collection PubMed
description BACKGROUND AND OBJECTIVE: Hypertension can lead to mood disorders that may worsen or ameliorate depending on the type of antihypertensive prescribed. Depression is associated with modifications in basal brain asymmetry particularly that of the frontal cortex, which is involved in blood pressure control. Furthermore, different vasoactive drugs may change the brain's asymmetry in a manner that contributes to cognition status. We studied the bilateral activity of several neuropeptidases in frontal cortex as a reflect of the functional status of certain neuropeptides involved in mood. METHODS: Using arylamide derivatives as substrates, we fluorometrically analysed the activity of these enzymes in the left and right frontal cortex of control untreated Wistar–Kyoto (WKY) and spontaneously hypertensive rats (SHRs) and compared their activities with WKY or SHR treated with the antihypertensive drugs captopril (CAP) and propranolol (PRO) or with the hypertensive N (G)-nitro-l-arginine methyl ester. SBP was also measured in all WKY and SHR groups. RESULTS: Untreated WKY, WKY treated with CAP or PRO and SHR treated with CAP exhibited normotensive values of SBP. However, WKY treated with N (G)-nitro-l-arginine methyl ester as well as untreated SHR and SHR treated with PRO and N(G)-nitro-l-arginine methyl ester demonstrated hypertensive values of SBP. Changes in the bilateral distribution of neuropeptidases were depending on the strain, the enzyme analysed and the drug used. Normotensive WKY groups (WKY, CAP, PRO) revealed intrahemispheric correlations mainly in the left hemisphere. In contrast, WKY treated with N(G)-nitro-l-arginine methyl ester and SHR groups demonstrated intrahemispheric correlations mainly in the right hemisphere. Interhemispheric correlations were mostly observed in WKY as well as in SHR groups with antihypertensive treatments (CAP, PRO). CONCLUSION: Our results suggest specific brain bilateral patterns of neuropeptidase activities in WKY that change in SHR. This observation may be related to the cognitive disorders that have been described in these animals and that change under antihypertensive or hypertensive drug's treatments.
format Online
Article
Text
id pubmed-6365296
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-63652962019-02-20 Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study Prieto, Isabel Segarra, Ana B. Villarejo, Ana B. de Gasparo, Marc Martínez-Cañamero, María M. Ramírez-Sánchez, Manuel J Hypertens ORIGINAL PAPERS: Treatment BACKGROUND AND OBJECTIVE: Hypertension can lead to mood disorders that may worsen or ameliorate depending on the type of antihypertensive prescribed. Depression is associated with modifications in basal brain asymmetry particularly that of the frontal cortex, which is involved in blood pressure control. Furthermore, different vasoactive drugs may change the brain's asymmetry in a manner that contributes to cognition status. We studied the bilateral activity of several neuropeptidases in frontal cortex as a reflect of the functional status of certain neuropeptides involved in mood. METHODS: Using arylamide derivatives as substrates, we fluorometrically analysed the activity of these enzymes in the left and right frontal cortex of control untreated Wistar–Kyoto (WKY) and spontaneously hypertensive rats (SHRs) and compared their activities with WKY or SHR treated with the antihypertensive drugs captopril (CAP) and propranolol (PRO) or with the hypertensive N (G)-nitro-l-arginine methyl ester. SBP was also measured in all WKY and SHR groups. RESULTS: Untreated WKY, WKY treated with CAP or PRO and SHR treated with CAP exhibited normotensive values of SBP. However, WKY treated with N (G)-nitro-l-arginine methyl ester as well as untreated SHR and SHR treated with PRO and N(G)-nitro-l-arginine methyl ester demonstrated hypertensive values of SBP. Changes in the bilateral distribution of neuropeptidases were depending on the strain, the enzyme analysed and the drug used. Normotensive WKY groups (WKY, CAP, PRO) revealed intrahemispheric correlations mainly in the left hemisphere. In contrast, WKY treated with N(G)-nitro-l-arginine methyl ester and SHR groups demonstrated intrahemispheric correlations mainly in the right hemisphere. Interhemispheric correlations were mostly observed in WKY as well as in SHR groups with antihypertensive treatments (CAP, PRO). CONCLUSION: Our results suggest specific brain bilateral patterns of neuropeptidase activities in WKY that change in SHR. This observation may be related to the cognitive disorders that have been described in these animals and that change under antihypertensive or hypertensive drug's treatments. Lippincott Williams & Wilkins 2019-03 2018-07-23 /pmc/articles/PMC6365296/ /pubmed/30044313 http://dx.doi.org/10.1097/HJH.0000000000001884 Text en Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle ORIGINAL PAPERS: Treatment
Prieto, Isabel
Segarra, Ana B.
Villarejo, Ana B.
de Gasparo, Marc
Martínez-Cañamero, María M.
Ramírez-Sánchez, Manuel
Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title_full Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title_fullStr Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title_full_unstemmed Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title_short Neuropeptidase activity in the frontal cortex of Wistar–Kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
title_sort neuropeptidase activity in the frontal cortex of wistar–kyoto and spontaneously hypertensive rats treated with vasoactive drugs: a bilateral study
topic ORIGINAL PAPERS: Treatment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365296/
https://www.ncbi.nlm.nih.gov/pubmed/30044313
http://dx.doi.org/10.1097/HJH.0000000000001884
work_keys_str_mv AT prietoisabel neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy
AT segarraanab neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy
AT villarejoanab neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy
AT degasparomarc neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy
AT martinezcanameromariam neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy
AT ramirezsanchezmanuel neuropeptidaseactivityinthefrontalcortexofwistarkyotoandspontaneouslyhypertensiveratstreatedwithvasoactivedrugsabilateralstudy